HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Erich H Simon Selected Research

Urokinase-Type Plasminogen Activator (Urokinase)

3/2006Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens.
4/2002Minimal residual disease in gastric cancer: evidence of an independent prognostic relevance of urokinase receptor expression by disseminated tumor cells in the bone marrow.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Erich H Simon Research Topics

Disease

2Neoplasms (Cancer)
03/2006 - 04/2002
1Metaplasia
03/2006
1Carcinoma (Carcinomatosis)
03/2006
1Stomach Neoplasms (Stomach Cancer)
04/2002
1Residual Neoplasm
04/2002

Drug/Important Bio-Agent (IBA)

2Plasminogen Activator Inhibitor 1IBA
03/2006 - 04/2002
2Urokinase Plasminogen Activator ReceptorsIBA
03/2006 - 04/2002
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
03/2006 - 04/2002
1UreaseIBA
03/2006
1Keratins (Keratin)IBA
04/2002